Phreesia (GB:0A23)
UK Market

Phreesia Stock Analysis & Ratings

GB:0A23 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$22.61
Average Volume (3M)132.00
Market Cap$1.18B
P/E RatioN/A
Next EarningsJun 02, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score8
EPS (TTM)0.00



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Phreesia’s market cap?
    Phreesia’s market cap is $1.18B.
      What is Phreesia’s price target?
      The average price target for Phreesia is $40.83. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $51.00 ,the lowest forecast is $29.00. The average price target represents 80.58% Increase from the current price of $22.61.
        What do analysts say about Phreesia?
        Phreesia’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
          When is Phreesia’s upcoming earnings report date?
          Phreesia’s upcoming earnings report date is Jun 02, 2022 which is in 6 days.
            How were Phreesia’s earnings last quarter?
            Phreesia released its earnings results on Mar 30, 2022. The company reported -$0.9 earnings per share for the quarter, beating the consensus estimate of -$1.033 by $0.133.
              Is Phreesia overvalued?
              According to Wall Street analysts Phreesia’s price is currently Undervalued.
                Does Phreesia pay dividends?
                Phreesia does not currently pay dividends.
                What is Phreesia’s EPS estimate?
                Phreesia’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Phreesia have?
                Phreesia has 52,160,000 shares outstanding.
                  What happened to Phreesia’s price movement after its last earnings report?
                  Phreesia reported an EPS of -$0.9 in its last earnings report, beating expectations of -$1.033. Following the earnings report the stock price went down -3.689%.
                    Which hedge fund is a major shareholder of Phreesia?
                    Among the largest hedge funds holding Phreesia’s share is Echo Street Capital Management LLC. It holds Phreesia’s shares valued at 32M.


                      Phreesia Stock Analysis

                      Smart Score
                      Price Target
                      ▲(80.58% Upside)
                      Strong Buy
                      The Phreesia stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description


                      Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.

                      Similar Stocks
                      Price & Change
                      Health Catalyst
                      Live Oak Bancshares
                      Boston Omaha
                      Fulgent Genetics

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis